Systemic adverse effects induced by the BNT162b2 vaccine are associated with higher antibody titers from 3 to 6 months after vaccination
Ryousuke Koike, Michiru Sawahata, Yosikazu Nakamura, Yushi Nomura, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
doi: https://doi.org/10.1101/2022.01.23.22269706
Ryousuke Koike
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University
Michiru Sawahata
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
3Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University
Yosikazu Nakamura
4Department of Public Health, Jichi Medical University
Yushi Nomura
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University
Otohiro Katsube
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
Koichi Hagiwara
3Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University
Seiji Niho
2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University
Norihiro Masuda
5Department of Surgery, National Hospital Organization Utsunomiya National Hospital
Takaaki Tanaka
6Department of Orthopaedic Surgery, National Hospital Organization Utsunomiya National Hospital
Kumiya Sugiyama
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
7Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University Saitama Medical Center

Article usage
Posted January 24, 2022.
Systemic adverse effects induced by the BNT162b2 vaccine are associated with higher antibody titers from 3 to 6 months after vaccination
Ryousuke Koike, Michiru Sawahata, Yosikazu Nakamura, Yushi Nomura, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
medRxiv 2022.01.23.22269706; doi: https://doi.org/10.1101/2022.01.23.22269706
Systemic adverse effects induced by the BNT162b2 vaccine are associated with higher antibody titers from 3 to 6 months after vaccination
Ryousuke Koike, Michiru Sawahata, Yosikazu Nakamura, Yushi Nomura, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
medRxiv 2022.01.23.22269706; doi: https://doi.org/10.1101/2022.01.23.22269706
Subject Area
Subject Areas
- Addiction Medicine (271)
- Allergy and Immunology (559)
- Anesthesia (135)
- Cardiovascular Medicine (1778)
- Dermatology (173)
- Emergency Medicine (317)
- Epidemiology (10834)
- Gastroenterology (595)
- Genetic and Genomic Medicine (2968)
- Geriatric Medicine (289)
- Health Economics (534)
- Health Informatics (1938)
- Health Policy (837)
- Hematology (295)
- HIV/AIDS (634)
- Medical Education (300)
- Medical Ethics (89)
- Nephrology (325)
- Neurology (2819)
- Nursing (152)
- Nutrition (435)
- Oncology (1475)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (259)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (382)
- Pediatrics (870)
- Primary Care Research (341)
- Public and Global Health (5393)
- Radiology and Imaging (1019)
- Respiratory Medicine (729)
- Rheumatology (330)
- Sports Medicine (280)
- Surgery (329)
- Toxicology (48)
- Transplantation (151)
- Urology (127)